Role of HDAC2 in the Pathophysiology of COPD
- 1 March 2009
- journal article
- review article
- Published by Annual Reviews in Annual Review of Physiology
- Vol. 71 (1) , 451-464
Abstract
Chronic obstructive pulmonary disease (COPD), characterized by progressive inflammation in the small airways and lung parenchyma, is mediated by the increased expression of multiple inflammatory genes. The increased expression of these genes is regulated by acetylation of core histones, whereas histone deacetylase 2 (HDAC2) suppresses inflammatory gene expression. In COPD, HDAC2 activity and expression are reduced in peripheral lung and in alveolar macrophages, resulting in amplification of the inflammatory response. Corticosteroid resistance in COPD occurs because corticosteroids use HDAC2 to switch off activated inflammatory genes. The reduction in HDAC2 appears to be secondary to the increased oxidative and nitrative stress in COPD lungs. Antioxidants and inhibitors of nitric oxide synthesis may therefore restore corticosteroid sensitivity in COPD, but this can also be achieved by low concentrations of theophylline and curcumin, which act as HDAC activators.Keywords
This publication has 72 references indexed in Scilit:
- The cytokine network in asthma and chronic obstructive pulmonary diseaseJournal of Clinical Investigation, 2008
- Curcumin Restores Corticosteroid Function in Monocytes Exposed to Oxidants by Maintaining HDAC2American Journal of Respiratory Cell and Molecular Biology, 2008
- Immunology of asthma and chronic obstructive pulmonary diseaseNature Reviews Immunology, 2008
- The functional significance of nuclear receptor acetylationSteroids, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- Developing COPD: a 25 year follow up study of the general populationThorax, 2006
- Relative Corticosteroid Insensitivity of Peripheral Blood Mononuclear Cells in Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005British Journal of Pharmacology, 2006
- Alveolar Macrophages as Orchestrators of COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2004
- Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPDEuropean Respiratory Journal, 2002